Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,039 | 78,190 | 102,294 | 39,165 | 58,539 |
| Marketable Securities | 120,964 | 16,921 | 19,530 | 46,208 | N/A |
| Receivables | 1,359 | N/A | N/A | N/A | N/A |
| Inventories | 1,231 | N/A | N/A | N/A | N/A |
| TOTAL | $174,649 | $101,096 | $126,554 | $85,996 | $61,529 |
| Non-Current Assets | |||||
| PPE Net | 2,205 | 2,011 | 1,437 | 0 | N/A |
| Investments And Advances | 0 | 32,021 | 0 | 0 | 0 |
| Intangibles | 59,561 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 441 | 493 | 528 | 0 | 0 |
| TOTAL | $62,207 | $34,525 | $1,965 | $N/A | $N/A |
| Total Assets | $236,856 | $135,621 | $128,519 | $85,996 | $61,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 51,949 | 3,546 | 7,568 | 1,775 | 568 |
| Accrued Expenses | 20,755 | 13,646 | 9,162 | 2,065 | 1,303 |
| TOTAL | $90,390 | $22,791 | $16,730 | $3,840 | $1,871 |
| Non-Current Liabilities | |||||
| Long Term Debt | 23,471 | 0 | N/A | N/A | N/A |
| Deferred Revenues | 17,686 | 5,599 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 439 | 590 | 715 | 0 | 0 |
| TOTAL | $24,617 | $2,096 | $715 | $N/A | $N/A |
| Total Liabilities | $115,007 | $24,887 | $17,445 | $3,840 | $1,871 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 94,781 | 63,375 | 63,375 | 47,710 | 37,362 |
| Common Shares | 9 | 6 | 6 | 5 | 4 |
| Retained earnings | -405,639 | -292,074 | -177,642 | -79,061 | -35,776 |
| Other shareholders' equity | -647 | -139 | -15 | 0 | 0 |
| TOTAL | $121,849 | $110,734 | $111,074 | $82,156 | $59,658 |
| Total Liabilities And Equity | $236,856 | $135,621 | $128,519 | $85,996 | $61,529 |